Evidence that the reduced number of natural killer cells in Type 1 (insulin-dependent) diabetes may be genetically determined

[1]  E. Jaeckel,et al.  Viruses and Diabetes , 2002, Annals of the New York Academy of Sciences.

[2]  B. Buckingham,et al.  Natural killer cell and islet killer cell activities in Type 1 (insulin-dependent) diabetes , 1986, Diabetologia.

[3]  L. Lanier,et al.  A model for the differentiation of human natural killer cells. Studies on the in vitro activation of Leu-11+ granular lymphocytes with a natural killer-sensitive tumor cell, K562 , 1985, The Journal of experimental medicine.

[4]  Hoskins,et al.  PATHOGENESIS OF INSULIN-DEPENDENT DIABETES: A ROLE FOR ACTIVATED T LYMPHOCYTES , 1984, The Lancet.

[5]  G. Trinchieri,et al.  Human natural killer cells: biologic and pathologic aspects. , 1984, Laboratory investigation; a journal of technical methods and pathology.

[6]  L. Lanier,et al.  A Human Natural Killer Cell‐Associated Antigen Defined by Monoclonal Antibody Anti‐Leu (NKP‐15): Functional and Two‐Color Flow Cytometry Analysis , 1984, Journal of leukocyte biology.

[7]  G. Trinchieri,et al.  Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1. , 1983, Journal of immunology.

[8]  J. Phillips,et al.  NKP-15: a monoclonal antibody reactive against purified human natural killer cells and granulocytes. , 1983, Immunology letters.

[9]  B. Haynes,et al.  Increased circulating Ia-antigen-bearing T cells in type I diabetes mellitus. , 1982, The New England journal of medicine.

[10]  J. Ortaldo,et al.  Natural killer cells: their roles in defenses against disease. , 1981, Science.

[11]  H. Mcdevitt,et al.  Insulin-dependent diabetes mellitus: the initial lesion. , 1981, The New England journal of medicine.

[12]  G. Trinchieri,et al.  INTERFERON MODULATION OF NATURAL KILLER CELL ACTIVITY * , 1980, Annals of the New York Academy of Sciences.

[13]  D. Doniach,et al.  COMPLEMENT-FIXING ISLET-CELL ANTIBODIES IN TYPE-I DIABETES: POSSIBLE MONITORS OF ACTIVE BETA-CELL DAMAGE , 1980, The Lancet.

[14]  P. Pozzilli,et al.  EVIDENCE FOR RAISED K-CELL LEVELS IN TYPE-I DIABETES , 1979, The Lancet.

[15]  Y. Koide,et al.  Augmentation of human natural cell-mediated cytotoxicity by a soluble factor. I. Production of N-cell-activating factor (NAF). , 1978, Journal of immunology.

[16]  J. Djeu,et al.  Augmentation of natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic target cells , 1977, International journal of cancer.

[17]  R. Herberman,et al.  Natural cytotoxic reactivity of human lymphocytes against a myeloid cell line: characterization of effector cells. , 1977, Journal of immunology.

[18]  D. Doniach,et al.  Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. , 1974, Lancet.

[19]  W. Gepts.  Pathologic Anatomy of the Pancreas in Juvenile Diabetes Mellitus , 1965, Diabetes.

[20]  P. Shragge,et al.  Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity , 2004, Journal of Clinical Immunology.

[21]  T. Timonen,et al.  Natural killer cell activity in asthma. , 1985, Clinical and experimental immunology.

[22]  B. Buckingham,et al.  Deficiency of monoclonal antibody (Leu 7) defined NK cells in newly diagnosed insulin-dependent diabetes mellitus. , 1984, Immunology letters.

[23]  R. Welsh.  Natural cell-mediated immunity during viral infections. , 1981, Current topics in microbiology and immunology.

[24]  A. Bøyum,et al.  Separation of leukocytes from blood and bone marrow. Introduction. , 1968 .